πŸ‡ΊπŸ‡Έ FDA
Patent

US 8449875

Targeting pseudotyped retroviral vectors

granted A61KA61K2039/5256A61K39/395

Quick answer

US patent 8449875 (Targeting pseudotyped retroviral vectors) held by The Regents of the University of California expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/5256, A61K39/395, A61K39/39558, A61K48/00